Oligometastatic Disease Detection with 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.

MLA

Artigas, Carlos, et al. “Oligometastatic Disease Detection with 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.” Cancers, vol. 13, no. 19, Oct. 2021, p. 4982. EBSCOhost, https://doi.org/10.3390/cancers13194982.

APA

Artigas, C., Diamand, R., Shagera, Q. A., Plouznikoff, N., Fokoue, F., Otte, F.-X., Gil, T., Peltier, A., Van Gestel, D., & Flamen, P. (2021). Oligometastatic Disease Detection with 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact. Cancers, 13(19), 4982. https://doi.org/10.3390/cancers13194982

Chicago

Artigas, Carlos, Romain Diamand, Qaid Ahmed Shagera, Nicolas Plouznikoff, Fabrice Fokoue, François-Xavier Otte, Thierry Gil, Alexandre Peltier, Dirk Van Gestel, and Patrick Flamen. 2021. “Oligometastatic Disease Detection with 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.” Cancers 13 (19): 4982. doi:10.3390/cancers13194982.